Patient Guide: COR3002: Amivantamab plus FOLFIRI vs Cetuximab/Bevacizumab plus FOLFIRI in KRAS/NRAS/BRAF wild-type metastatic colorectal cancer (COR3002)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTCOR3002
Status: 🟢 Enrolling Now
Condition: Colorectal cancer
Phase: PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily